Physical Medicine & Rehabilitation, Pain Medicine · Tampa, FL
NPI
1134170038
Since 2006
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2333 W Hillsborough Ave Ste 100
Tampa, FL, 33603
Phone (813) 872-4492
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
1,781 services
Medicare patients, 2024
254
Average age 67
Drug cost, 2024
$1.1M
15,340 prescriptions
Company payments, 2025
$5,871
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Guirguis was code 99213 (office e&m - established), 393 times for 173 patients. In total Robert Guirguis billed 1,781 services in 53 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 393 | 173 | $64.96 | $26K |
| 99214 Office E&M - Established | Office | 222 | 107 | $87.21 | $19K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 204 | 24 | $0.70 | $143 |
| 62370 Musculoskeletal | Office | 70 | 17 | $67.24 | $4,707 |
| 80307 Drug Tests | Office | 69 | 64 | $60.90 | $4,202 |
| 64555 Musculoskeletal | Facility | 54 | 20 | $200.05 | $11K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 50 | 49 | $153.46 | $7,673 |
| 95886 Electrical Nerve Conductivity | Office | 49 | 25 | $72.27 | $3,541 |
| 64490 Nerve Block Injection - Back | Facility | 34 | 16 | $108.60 | $3,692 |
| 64491 Nerve Block Injection - Back | Facility | 34 | 16 | $61.51 | $2,091 |
| 63650 Neurostimulator - Back | Facility | 34 | 11 | $249.55 | $8,485 |
| 99204 Office E&M - New | Office | 31 | 31 | $111.41 | $3,454 |
| 95913 Electrical Nerve Conductivity | Office | 28 | 28 | $212.57 | $5,952 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 23 | 20 | $112.14 | $2,579 |
| 99441 Telephone Services | Office | 23 | 23 | $43.25 | $995 |
By year: 2022 $167K for 2,197 services; 2023 $219K for 2,800 services; 2024 $133K for 1,781 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 69 | 64 | $60.90 | $4,202 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 50 | 49 | $153.46 | $7,673 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 23 | 20 | $112.14 | $2,579 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert Guirguis prescribed most often to Medicare patients was Oxycodone Hcl, with 2,941 prescriptions and refills. In total Robert Guirguis wrote 15,340 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 2,941 | 2,951 | 405 | $62K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,116 | 2,122 | 445 | $66K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,831 | 1,833 | 311 | $67K |
| Morphine Sulfate Er Morphine Sulfate | 1,330 | 1,339 | 212 | $34K |
| Hydromorphone Hcl Generic | 753 | 755 | 147 | $20K |
| Celecoxib Generic | 628 | 657 | 182 | $21K |
| Morphine Sulfate Generic | 389 | 389 | 76 | $13K |
| Gabapentin Generic | 327 | 352 | 89 | $3,805 |
| Pregabalin Generic | 304 | 341 | 66 | $6,643 |
| Tramadol Hcl Generic | 286 | 286 | 75 | $2,603 |
| Cyclobenzaprine Hcl Generic | 270 | 274 | 89 | $12K |
| Xtampza Er Oxycodone Myristate | 238 | 238 | 52 | $149K |
| Ondansetron Odt Ondansetron | 221 | 238 | 75 | $7,554 |
| Diclofenac Sodium Generic | 214 | 229 | 82 | $20K |
| Ropinirole Hcl Generic | 197 | 243 | 46 | $1,047 |
Brand drugs: - claims; generic drugs: 14,070 claims; opioid claims: 10,342.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert Guirguis $5,871 ($5,871 in general payments such as food, travel and fees) from 21 companies. The largest payer was Medtronic, Inc. with $2,266.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 46 | $2,266 |
| Boston Scientific Corporation BSX | 32 | $735 |
| Globus Medical, Inc. GMED | 11 | $630 |
| Curonix LLC | 9 | $348 |
| Abbott Laboratories ABT | 5 | $284 |
| Abbvie Inc. ABBV | 15 | $274 |
| Collegium Pharmaceutical, Inc. COLL | 33 | $243 |
| Pfizer Inc. PFE | 9 | $196 |
| TerSera Therapeutics LLC | 8 | $181 |
| SPR Therapeutics, Inc | 9 | $143 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.